Sign in
4

Changes in Ownership

Nautilus Biotechnology, Inc. Filed Acc 0001062993-21-011100

Director bought 100,000 shares at $5.30 ($529,890)

From the SEC's structured data for this filing

Trades in this filing

McIlwain Matthew S · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-11-15 Purchase : show line 1 in the form +100,000 $5.30 $529,890 459,075 D
Open-market purchases · 100,000 sh · avg $5.30 · $529,890
Loading xslF345X03/form4.xml…